JS, P., EG, W., K, B., L, L., N, O., T, R., . . . P, A. (2023). CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review. Diabetes, obesity & metabolism, 25(4), 916. https://doi.org/10.1111/dom.14962
Chicago Style (17th ed.) CitationJS, Pemberton, Wilmot EG, Barnard-Kelly K, Leelarathna L, Oliver N, Randell T, Taplin CE, Choudhary P, and Adolfsson P. "CGM Accuracy: Contrasting CE Marking with the Governmental Controls of the USA (FDA) and Australia (TGA): A Narrative Review." Diabetes, Obesity & Metabolism 25, no. 4 (2023): 916. https://doi.org/10.1111/dom.14962.
MLA (9th ed.) CitationJS, Pemberton, et al. "CGM Accuracy: Contrasting CE Marking with the Governmental Controls of the USA (FDA) and Australia (TGA): A Narrative Review." Diabetes, Obesity & Metabolism, vol. 25, no. 4, 2023, p. 916, https://doi.org/10.1111/dom.14962.